Raglan Capital Co-Founded Companies
Spun out of Open Orphan & listed on AIM in July 2021. Commenced trading on OTCQB in the US in March 2022.
Listed on the AIM and Euronext exchanges in June 2019 through the reverse takeover of Venn Life Sciences and acquired hVIVO plc in January 2020.
Listed on the London AIM and Dublin Euronext exchanges in 2016, raising £20m in funding. Now listed on NASDAQ.
Raised over $50m through its floatation on the London and Dublin stock exchanges.
Raglan Capital Co-Founded companies
Spun out of Open Orphan & listed on AIM in July 2021. Commenced trading on OTCQB in the US in March 2022.
Listed on the AIM and Euronext exchanges in June 2019 through the reverse takeover of Venn Life Sciences and acquired hVIVO plc in January 2020.
Listed on the London AIM and Dublin Euronext exchanges in 2016, raising £20m in funding. Now listed on NASDAQ.
Raised over $50m through its floatation on the London and Dublin stock exchanges.
Raglan Capital: Creating in-house companies that can be rapidly listed on the stock exchange.
Raglan has a long successful history of providing corporate finance and investment banking services to a range of Irish and international companies. For the last number of years, Raglan ceased providing any third-party corporate finance services and is now solely focused upon creating our own companies in-house that can then be rapidly listed on the London stock exchange. Our general target is to complete an IPO within two years post inception of the company.